A Molecular Taxonomy of Urothelial Carcinoma
Expression microarray · human · 308 samples
- What it is
- Expression microarrayGene activity read on a chip (the older technology that RNA-seq replaced).
- Organism
- Homo sapiens (human)
- Topic
- Bladder cancerThis series is part of our curated briefing on it.
- Samples
- 308 samples: 308 samples, each with a distinct title — no replicated groupsGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed expression table (series matrix) and the array files, from NCBI.
Read the full summary ↓
Direct links to NCBI, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need.
Whole study · RAW.tar
Everything the authors deposited as one archive (GSE32894_RAW.tar), including the raw array or instrument files. Can be large; the picker in step 2 takes just the samples you need.
What the files usually look like: For arrays the series matrix is normally the normalised expression table you want; the raw array files (CEL and similar) are in the RAW.tar.
Also filed as BioProject PRJNA146635. Searching any of these in the dataset finder brings you back here.
Any grouping that defines a comparison lives in the sample characteristics, which GEO records separately from the titles.
How we read this: Read from 308 sample titles: 308 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM814052 UC_0001_1.a1.lbe1
- GSM814053 UC_0002_1.RNA.e1.a1.lbe1
- GSM814054 UC_0003_1.RNA.e1.a1.lbe1
- GSM814055 UC_0006_2.a1.lbe1
- GSM814056 UC_0007_1.RNA.e1.a1.lbe1
- GSM814057 UC_0008_1.RNA.e1.a1.lbe1
- GSM814058 UC_0009_1.RNA.e1.a1.lbe1
- GSM814059 UC_0010_1.a1.lbe1
- GSM814060 UC_0016_1.RNA.e1.a1.lbe1
- GSM814061 UC_0017_1.a1.lbe1
- GSM814062 UC_0018_1.a1.lbe1
- GSM814063 UC_0022_1.RNA.e1.a1.lbe1
- GSM814064 UC_0023_1.a1.lbe1
- GSM814065 UC_0024_1.a1.lbe1
- GSM814066 UC_0025_1.RNA.e1.a1.lbe1
- GSM814067 UC_0027_1.a1.lbe1
- GSM814068 UC_0030_1.RNA.e1.a1.lbe1
- GSM814069 UC_0033_2.RNA.e1.a1.lbe1
- GSM814070 UC_0034_1.RNA.e1.a1.lbe1
- GSM814071 UC_0037_1.a1.lbe1
- GSM814072 UC_0040_1.RNA.e1.a1.lbe1
- GSM814073 UC_0041_2.RNA.e1.a1.lbe1
- GSM814074 UC_0042_2a.RNA.e1.a1.lbe1
- GSM814075 UC_0043_1.RNA.e1.a1.lbe1
- GSM814076 UC_0046_1.RNA.e1.a1.lbe1
- GSM814077 UC_0049_2.a1.lbe1
- GSM814078 UC_0050_1.a1.lbe1
- GSM814079 UC_0053_1.RNA.e1.a1.lbe1
- GSM814080 UC_0055_1.a1.lbe1
- GSM814081 UC_0059_1.RNA.e1.a1.lbe1
- GSM814082 UC_0060_4.RNA.e1.a1.lbe1
- GSM814083 UC_0066_3.RNA.e1.a1.lbe1
- GSM814084 UC_0067_1.RNA.e1.a1.lbe1
- GSM814085 UC_0069_1.RNA.e1.a1.lbe1
- GSM814086 UC_0070_1.a1.lbe1
- GSM814087 UC_0075_1.RNA.e1.a1.lbe1
- GSM814088 UC_0077_1.RNA.e1.a1.lbe1
- GSM814089 UC_0080_1.RNA.e1.a1.lbe1
- GSM814090 UC_0086_1.RNA.e1.a1.lbe1
- GSM814091 UC_0089_1.a1.lbe1
+ 268 more — browse all 308 samples with per-sample file links →
- GSE176493 Comprehensive target engagement by EZH2 inhibitor CPI-0209 allows for preferential targeting of ARID1A mutant urothelial carcinoma 252 samples same disease briefing · shares urothelial
- GSE217413 Cisplatin resistance driver gene CLSPN product is a target for immunotherapy in urothelial carcinoma. 4 samples same disease briefing · shares urothelial
- GSE181389 Transcriptome profiling of HOXA13 and HOXB13 expression knockdown in bladder cancer cell lines. 59 samples same disease briefing
- GSE149652 Intratumoral CD4+ T cells mediate anti-tumor cytotoxicity in human bladder cancer 28 samples same disease briefing
- GSE171024 Potential Roles of IGF2BP3 in Bladder Cancer 12 samples same disease briefing
- GSE193755 Human bladder cancer cell line high throughput sequencing - genes regulated by hMSH2 12 samples same disease briefing
- GSE214886 Downregulation of CBX7 induced by EZH2 upregulates FGFR3 expression to reduce sensitivity to cisplatin in bladder cancer 12 samples same disease briefing
- GSE211924 UCHL5 promotes Tumorigenesis of Bladder Cancer by Activating AKT/mTOR signaling pathway and targeting c-myc, SLC25A19, and ICAM5. 9 samples same disease briefing
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.